Unity Biotechnology, Inc. (UBX) Social Stream
Unity Biotechnology Inc (UBX) Price Targets From Analysts
Use the tables below to see what analysts covering Unity Biotechnology Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
UBX's average price target has moved up $1.31 over the prior 12 months.
UBX reports an average of 148.13% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
UBX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
UBX's average broker recommendation rating improved by 1.88 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Unity Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 387.49% of them.
- Unity Biotechnology Inc's average analyst price target is greater than 23.76% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, Unity Biotechnology Inc's variance in analysts' estimates is lower than -273.58% of them.
- Unity Biotechnology Inc's number of analysts covering the stock is higher than 328.88% of stocks in the small market cap category.
In the Pharmaceutical Products industry, TYRA, TYME, and TXMD are the three stocks most similar to Unity Biotechnology Inc regarding the price target and analyst recommendation information presented here.
Is UBX a Buy, Hold or Sell? See the POWR Ratings now!